2020 Conference Announcement, Res Rep Gastroenterol Vol: 3 Issue: 1
Digestive Disease 2020 scheduled at Venice, Italy during June 22-23, 2020
Professor of Microbiology and Immunology, National Research Center, Egypt E-mail: [email protected]
Digestive Diseases market is expected to grow from USD 17.27 billion in 2016 and reach USD 19.79 billion in 2022, growing at a CAGR of 2.3% during the forecast period. Our industry experts anticipate that within the Digestive diseases market, the GIT Anti-inflammatory drug will grow at the fastest CAGR ranging from 1% to .5%, during the forecast period. Based on the geographic regions, our experts anticipate that Europe will be the fastest-growing segment during the forecast period. The Europe region will grow at a CAGR ranking from 1% to 0.3% by 2022.
Gastrointestinal (GI) or gastroenterology is the branch of medicine related to the GI tract (stomach and intestines) and the accessory organs of digestion (from the mouth to the anus). Some of the conditions treated under this specialty include but are not limited to: Crohn’s disease, gastroesophageal reflux disease (GERD), inflammatory bowel disease, irritable bowel syndrome, peptic ulcer disease, celiac disease, colon cancer, heartburn, gastric cancer, diverticulitis, and ulcerative colitis.
The size of the global gastrointestinal therapeutics market is expected to reach USD 13.8 billion by 2020, accelerating at a CAGR of 6.5% between 2015-2020. This growth in market size is attributed to numerous factors including increasing consumption of biologics, tentative approval of late stage molecules, development of novel therapies using innovative technologies, and improved diagnostic tools increasing the treatment-seeking population.
Additionally, a sudden increase in the number of gastric surgeries across the globe is directly impacting the growth of post-surgical gastroparesis cases across the globe, which will directly propel growth within the gastroparesis drugs market over the next few years. Due to this primary growth factor, the global gastroparesis drugs market will increase USD 940 million between 2016-2021, exceeding USD 7.1 billion in market size by the end of the forecast period. Other factors driving the growth of this market include unmet needs in the industry to increase the R&D in the field and the rising cases of diabetes fueling the prevalence of diabetic gastroparesis. Other insights provided within gastroenterology market reports include:
Gastroenterology Market Insight
The increasing consumption of biologics for inflammatory bowel diseases (IBD) will be one of the major factors that will have a positive impact on the growth of the gastrointestinal therapeutics market size in the coming years. The emergence of biosimilars and the adoption of biosimilars as they contain active pharmaceutical ingredients that are identical to their originator biologic compounds and are also less expensive than biologics will gain traction in this market.
By analyzing the importance of gastrointestinal diseases, Meetings International is organizing 2nd International Conference on Digestive Disease (Digestive Disease 2020) during June 22-23, 2020 in Venice, Italy based on the theme “Recent Advancements in Hepatology & Liver Diseases". Scientific sessions of Venice Digestive Disease conference include Advancements in Digestive Disease Treatment, Gastroenterology & Pregnancy, Hepatic Disorders, Pediatric Gastroenterology, Neuro-Gastroenterology, Clinical Research in Gastroenterology, Gastroenteritis, Digestive Disorders, Endoscopic retrograde cholangiopancreatography & Endoscopic ultrasound and liver biopsy. Digestive Disease meeting embraces with Keynote Session, Oral Session, Poster Session, Young Researchers Session and Exhibitor Session.
Venice is hosting the Digestive Disease 2020 during June 22-23, 2020. Venice is the capital city of north-eastern Italy as well as famous water places in the world. The special tourist spots Venice are City of Bridge, The central square, Saint Mark's Basilica, Doge's Palace, St. Mark's Square, Rialto Bridge.
For more details, connect to
Conference Manager | Digestive Disease 2020
Email: [email protected]
Phone/Whats App: +65 3158 1626
Digestive Disease Previous Conference images held in Madrid Spain